News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Embera NeuroTherapeutics, Inc. To Receive Grant For Clinical Trial Through New Crowd Funding Platform


7/1/2014 11:19:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON & SHREVEPORT, La.--(BUSINESS WIRE)--Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for smoking cessation and other addictions, today announced that Sound Affects Life, a 501(c)3 not-for-profit charity, has selected Embera as part of its inaugural group of companies to receive a grant funded by contributions through Soundaffectslife.org. Soundaffectslife.org, which launches today, is a new crowd funding platform designed to connect individuals with organizations that are actively seeking improved outcomes in cancer. The grant will support the evaluation of EMB-001, the company’s lead drug candidate, in a Phase 1 clinical trial enrolling individuals who smoke but are otherwise healthy.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES